Anti-Müllerian hormone may contribute to infertility in polycystic ovary syndrome


High levels of anti-Mullerian hormone (AMH) have traditionally been thought of as merely a passive byproduct of polycystic ovary syndrome (PCOS), but a new preclinical study by our Reproductive Endocrine Laboratory Director Daylon James, PhD and team suggests that the hormone plays an active role in the disorder and may contribute to problems with ovulation and fertility. Learn more here

Weill Cornell Medicine
Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine

1305 York Avenue, 6th Floor
New York, NY 10021 Phone: (646) 962-2764